Vilazodone Hydrochloride Tablet
Product Images NDC 82804-128

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vilazodone Hydrochloride (NDC 82804-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-128-30 (40mg 30label)

Label for Vilazodone HCl 40 mg tablets by Proficient Rx LP. Contains 30 blue, ellipse-shaped, biconvex film-coated tablets, debossed with "MV" on one side and "16" on the other. Manufactured by MSN Laboratories Private Limited, Telangana, India. Includes barcode, QR code, and storage instructions at 25°C (77°F).*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure of vilazodone hydrochloride, showing a complex molecular arrangement including indole and piperazine rings, a cyano group, an amide functional group, and a hydrochloride moiety.*

FDA Label Image

Figure 1 (Vii00 0013 02)

A dot plot chart illustrating pharmacokinetic (PK) fold changes in Cmax and AUC for vilazodone hydrochloride when co-administered with various substances including ethanol, CYP3A4 inhibitors (ketoconazole), CYP3A4 inducers (carbamazepine), and proton pump inhibitors (pantoprazole). The x-axis shows change relative to reference, ranging from 0.5 to 2.0 with error bars indicating 90% confidence intervals.*

FDA Label Image

Figure 2 (Vii00 0013 03)

A chart depicting the pharmacokinetic fold changes and 90% confidence intervals in plasma concentration for various substrates, including CYP3A4, CYP1A2, CYP2D6, CYP2C9, CYP2C19, and P-glycoprotein substrates, relative to a reference point.*

FDA Label Image

Figure 3 (Vii00 0013 04)

A forest plot chart depicting pharmacokinetic (PK) parameters Cmax and AUC for vilazodone hydrochloride across population subgroups: age over 65 years, female gender, and varying degrees of renal and hepatic impairment. The chart shows fold changes with 90% confidence intervals relative to reference groups, illustrating comparative drug exposure levels.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.